The first phase of Fujifilm Biotechnologies’ $3.2-billion large-scale cell culture biopharmaceutical manufacturing plant in North Carolina is scheduled to begin operating this year.

Market Growth Driven by Rapid Disposable Technology Adoption, Expanding Biopharmaceutical Sector, and Government Support for ...

Donaldson Company, Inc. (NYSE: DCI) (Donaldson or the Company), a global leader in technology-led filtration products and solutions, today reported third quarter fiscal 2025 generally accepted ...

Canadian mining developer Solaris Resources (TSX: SLS)(NYSE: SLSR) has secured a $200 million financing deal from streaming and royalty company Royal Gold (NASDAQ: RGLD) to advance its Warintza ...

Solaris supported the R&D phase by providing benchtop bioreactors, showcasing our commitment to innovative collaborations. We are also working with a food-tech company focusing on cultivated meat, ...

The global bioreactors market is estimated to grow from $16.7 billion in 2024 to $51.7 billion by 2035, representing a CAGR of 11.1% during the forecast period from 2024 to 2035.

Global Bioreactors Market Global Bioreactors Market Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication ...

In November 2021, Solaris became part of the Donaldson Company based in Bloomington, MN. The company exports bioreactors and fermenters worldwide and is among the leaders in the industry.